Image 1
Tri-sprintec Kit
Product Images NDC 0555-9018
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tri-sprintec (NDC 0555-9018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This appears to be a list of studies that have investigated the use of contraceptives by women. The studies include NICHD Women's Contraceptive Study in 2002 and 2013, French E3N cohort Study in 2005, Shangai Women's Health Study in 2009, The Nurses' Health Study in 2010, and Danish Sex Hormone Register Study in 2017. The table below these studies contains estimates of the effect of the contraceptive use on some measure, but without knowing the variable that is being estimated it is unclear what this table is measuring.*
Image 3
Image 4
Image 5
This text appears to be a chart or table describing different birth control methods and the typical number of pregnancies per 100 women per year associated with their use. The chart lists various methods including implants, injections, intrauterine devices, sterilization, birth control pills, skin patches, vaginal rings with hormones, condoms, diaphragms, spermicide, and withdrawal. It also shows that the number of pregnancies per year varies greatly depending on the chosen method, ranging from fewer than one pregnancy per 100 women to 85 or more pregnancies per 100 women.*
Image 6
Tri-Spitatted is not available as the text contains random characters and incomplete words.*
Image 7
This text contains information about the drug Tri-Sprintec(norgestimate and ethinyl estradiol tablets USP), its usual dosage of one tablet daily for 28 consecutive days per menstrual cycle as prescribed. It also provides instructions on how to store the drug and warnings to protect it from the light and keeping it out of reach of children. The text also instructs the dispenser to provide the informational pieces to the patient with each prescription.*
Image 8
This is a description of Tri-Sprinteé, which is an oral contraceptive intended to prevent pregnancy. It comes in a pack of 6 blister cards, each containing 28 tablets of 0.18mg norgestimate, USP and 0.035mg ethinyl estradiol, USP. The tablets come in different colors: blue (inert ingredients), gray (0.035mg ethinyl estradiol, USP), light blue (0.215mg norgestimate, USP and 0.035mg ethinyl estradiol, USP), and white (0.25mg norgestinate, USP and 0.035mg ethinyl estradiol, USP). It is important to note that this product does not protect against sexually transmitted diseases.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
